ARTICLE | Company News
Sanofi, Program for Appropriate Technology in Health sales and marketing update
September 1, 2014 7:00 AM UTC
Sanofi and PATH began delivering the first large-scale batches of antimalarial treatments manufactured with a semisynthetic artemisinin derivative to countries in Africa. Artemisinin is the main ingre...